HMOX1 and metabolic dysfunction-associated steatohepatitis: HO-1 mRNA expression in patients with NASH, chronic hepatitis C, and liver cirrhosis was more than that in controls (P < 0.05, P < 0.001, and P < 0.001, respectively).